Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -20.568% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) COc1ccc(-c2csc(-c3cccs3)n2)c(OC)c1
(b) Cc1ccc(NC(=O)COc2coc(CN3CCc4ccccc4C3)cc2=O)cc1Cl
(c) O=S(=O)(NCc1cn2ccsc2n1)c1ccc2c(c1)OCCO2
(d) COc1ccc(NC(=O)C(=S)NC2CCCCC2)cc1
(e) Cc1ccccc1OCC(=O)NNC=O
Answer: d. COc1ccc(NC(=O)C(=S)NC2CCCCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)C(=S)NC2CCCCC2)cc1
COc1ccc(NC(=O)C(=S)NC2CCCCC2)cc1
2-(cyclohexylamino)-N-(4-methoxyphenyl)-2-sulfanylideneacetamide